Resistance to fever induction and impaired acute-phase response in interleukin-1β-deficient mice-Reference-Cited by-同舟云学术

Resistance to fever induction and impaired acute-phase response in interleukin-1β-deficient mice

Published:1995-07 Issue:1 Volume:3 Page:9-19
ISSN:1074-7613
Container-title:Immunity
language:en
Short-container-title:Immunity

Author:

Zheng Hui,Fletcher Daniel,Kozak Wieslaw,Jiang Minghao,Hofmann Kathryn J.,Corn Carole A.,Soszynski Darlusz,Grabiec Christina,Trumbauer Myrna E.,Shaw Alan,Kostura Matthew J.,Stevens Karla,Rosen Hugh,North Robert J.,Chen Howard Y.,Tocci Michael J.,Kluger Matthew J.,Van der Ploeg Lex H.T.

Publisher

Elsevier BV

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference63 articles.

1. Biology of multifunctional cytokines: IL-6 and related molecules (IL-1 and TNF);Akira;FASEB J.,1990

2. A soluble receptor for interleukin1 β encoded by vaccinia virus: a novel mechanism of virus modulation of the host response to infection;Alcami;Cell,1992

3. Interleukin-1 receptor antagonist;Arend;Adv. Immunol.,1993

4. Contact and delayed hypersensitivity in the mouse;Asherson;Immunology,1968

5. Regulation of major acute-phase plasma proteins by hepatocyte-stimulating factors of human squamous carcinoma cells;Baumann;J. Cell Biol.,1986

Cited by 338 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of a short sequence motif in the influenza A virus pathogenicity factor PB1-F2 required for inhibition of human NLRP3;Journal of Virology;2024-05-14

2. The role of interleukin-1 in perinatal inflammation and its impact on transitional circulation;Frontiers in Pediatrics;2023-03-13

3. Evolutionary features of ligands and their receptors via protein–protein interactions and essentiality in primates;Genes to Cells;2023-01-14

4. Respiratory viruses and the inflammasome: The double-edged sword of inflammation;PLOS Pathogens;2022-12-29

5. Inhibition of interleukin-1β reduces myelofibrosis and osteosclerosis in mice with JAK2-V617F driven myeloproliferative neoplasm;Nature Communications;2022-09-13